Skip to content
Biodatica
Start free

Kriya Therapeutics, Inc.

MORRISVILLE, NC · also filed as None

OncologyFormed
Compare Sign in to watch

What changed

$321M raise filed (Form D/A)

10mo agoRaise filed (Form D)Sep 10, 2025Source filing (opens the source filing in a new tab)

Momentum

43no change

Momentum 43 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

~120months

The last disclosed raise still models out past a year.

Stage

Formed

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Filing

    Form D/A · $321M

    Sep 10, 2025

    Kriya Therapeutics, Inc. · private raise, self-reported by the issuer

    SEC EDGAR · 0001811209-25-000003 (opens the source filing in a new tab)

  2. Grant

    R35 · $386k · non-dilutive

    Jul 1, 2024

    UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STONE, MICHAEL D · NIGMS · award ends Jun 30, 2029 · Structure and Dynamics of Telomeres and Telomerase

    NIH RePORTER · NIH RePORTER 11124062 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources